Security Snapshot

Encompass Health Corp - COMMON STOCK (EHC) Institutional Ownership

CUSIP: 29261A100

13F Institutional Holders and Ownership History from Q1 2016 to Q2 2026

Latest Period

Q2 2026

Institutions Reporting

594

Shares (Excl. Options)

95,328,005

Price

$101.08

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Latest holder snapshot 5 signals
Portfolio coverage rank
0.01%
Share change
-578,566
Value change
-$55,716,365
Number of holders
594
Issuer context Names, identifiers, and filing context for this profile. 3 identity fields
Shares outstanding
99,141,667
SEC-reported price per share
$110.72
Insider filing price
$110.72
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors

Key facts

  • EHC - Encompass Health Corp - COMMON STOCK is tracked under CUSIP 29261A100.
  • 594 institutions reported positions in Q2 2026.
  • 5 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 579 to 594 between Q1 2026 and Q2 2026.
  • SEC-reported value moved from $9,307,492,139 to $9,624,391,833.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 594 institutions filings for Q2 2026.

Open SEC evidence

Security key

29261A100

Latest holder period

Q2 2026

13F holders

594

13D/G owners

5

CIK / CUSIP context first

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
5
Security
EHC
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
VANGUARD CAPITAL MANAGEMENT LLC 5.3% $506,248,256 5,233,622 Vanguard Capital Management 31 Mar 2026
PRICE T ROWE ASSOCIATES INC /MD/ 5.1% $559,825,232 5,056,225 T. Rowe Price Associates, Inc. 30 Jun 2026
Invesco Ltd. 4.9% $535,910,573 4,972,725 Invesco Ltd. 31 Dec 2025
VANGUARD PORTFOLIO MANAGEMENT LLC 5% -0.6% $546,486,019 -$3,969,644 4,935,748 -0.72% Vanguard Portfolio Management 30 Jun 2026
WELLINGTON MANAGEMENT GROUP LLP 4% $456,931,210 4,030,442 Wellington Management Group LLP 31 Dec 2024

As of 30 Jun 2026, 594 institutional investors reported holding 95,328,005 shares of Encompass Health Corp - COMMON STOCK (EHC). This represents 96% of the company’s total 99,141,667 outstanding shares.

13F concentration

Top 25 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
60%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
BlackRock, Inc. 11% 10,484,385 -2.6% 0.02% $1,059,761,675
PRICE T ROWE ASSOCIATES INC /MD/ 5.1% 5,055,801 +9.9% 0.05% $511,042,000
VANGUARD PORTFOLIO MANAGEMENT LLC 5% 4,924,664 -0.7% 0.02% $497,785,037
VANGUARD CAPITAL MANAGEMENT LLC 4.5% 4,475,896 +0.22% 0.01% $452,423,568
WELLINGTON MANAGEMENT GROUP LLP 3.3% 3,278,739 -15% 0.06% $331,414,937
STATE STREET CORP 3.2% 3,185,798 +1.3% 0.01% $322,020,462
CITADEL ADVISORS LLC 2.6% 2,563,104 +401% 0.15% $259,078,552
ALLIANCEBERNSTEIN L.P. 2.5% 2,471,751 -5.7% 0.09% $239,092,474
FULLER & THALER ASSET MANAGEMENT, INC. 2.5% 2,460,657 +10% 0.68% $248,723,177
TWO SIGMA INVESTMENTS, LP 2.3% 2,267,668 +2.1% 0.17% $229,215,881
GEODE CAPITAL MANAGEMENT, LLC 1.9% 1,890,743 -0.42% 0.01% $191,163,529
DIMENSIONAL FUND ADVISORS LP 1.8% 1,743,028 +4.1% 0.03% $176,185,032
GOLDMAN SACHS GROUP INC 1.6% 1,550,797 -14% 0.02% $156,754,618
Invesco Ltd. 1.2% 1,161,108 -66% 0.01% $117,364,796
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 1.2% 1,156,930 -2.2% 0.05% $116,942,484
NORGES BANK 1.2% 1,154,864 0.01% $116,733,653
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC 1.2% 1,151,085 +43% 0.35% $116,351,672
MORGAN STANLEY 1.2% 1,146,872 +28% 0.01% $115,926,016
JPMORGAN CHASE & CO 1.1% 1,133,561 -8% 0.01% $114,840,512
RAYMOND JAMES FINANCIAL INC 1.1% 1,064,233 -0.26% 0.03% $107,572,603
AMERICAN CENTURY COMPANIES INC 1.1% 1,050,470 +40% 0.05% $106,181,901
Eversept Partners, LP 1% 1,026,919 +429% 5.7% $103,800,973
BROWN ADVISORY INC 1% 1,012,731 +46% 0.16% $102,366,881
Holocene Advisors, LP 0.99% 977,634 +550% 0.23% $98,819,245
NORTHERN TRUST CORP 0.98% 970,684 +1.3% 0.01% $98,116,739

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
42
Latest
Q2 2026
Rows shown
1-25 of 42
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q2 95,328,005 $9,624,391,833 -$55,716,365 $101.08 594
2026 Q1 95,920,242 $9,307,492,139 -$154,015,566 $96.73 579
2025 Q4 97,436,367 $10,345,109,667 +$354,136,059 $106.14 592
2025 Q3 93,686,723 $11,896,053,253 -$135,234,226 $127.02 603
2025 Q2 94,968,235 $11,642,879,160 -$49,112,078 $122.63 603
2025 Q1 95,615,973 $9,683,390,579 +$19,223,151 $101.28 534
2024 Q4 95,688,892 $8,837,272,246 -$61,337,557 $92.35 540
2024 Q3 95,659,986 $9,240,740,107 -$28,092,689 $96.64 478
2024 Q2 95,815,590 $8,220,005,999 -$60,422,230 $85.79 476
2024 Q1 97,703,422 $8,070,672,559 +$16,673,851 $82.58 433
2023 Q4 97,223,556 $6,487,871,907 +$126,291,067 $66.72 429
2023 Q3 94,211,639 $6,326,664,657 +$24,828,296 $67.16 410
2023 Q2 93,484,125 $6,330,038,243 +$9,034,551 $67.71 380
2023 Q1 93,612,402 $5,065,388,681 -$121,237,618 $54.10 384
2022 Q4 96,070,844 $5,746,729,705 +$9,797,176 $59.81 368
2022 Q3 96,958,614 $4,388,175,997 +$140,328,300 $45.23 325
2022 Q2 91,599,655 $5,129,979,182 -$75,940,650 $56.05 367
2022 Q1 94,188,292 $6,688,146,207 +$180,281,875 $71.11 399
2021 Q4 91,512,815 $5,963,921,386 -$30,961,306 $65.26 397
2021 Q3 91,185,917 $6,852,134,068 -$52,652,075 $75.04 430
2021 Q2 91,493,382 $7,141,491,218 +$213,843 $78.03 409
2021 Q1 92,312,962 $7,562,692,331 +$3,926,033 $81.90 398
2020 Q4 92,274,413 $7,632,521,664 -$63,397,436 $82.69 396
2020 Q3 92,464,254 $6,004,059,199 +$39,210,352 $64.98 367
2020 Q2 91,927,091 $5,693,124,070 +$51,792,099 $61.93 368
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .